National Pancreatic Cancer Day

Group of diverse individuals wearing purple shirts, standing together with banners and ribbons, city park background. — National pancreatic cancer day illustration

Welcome to National Pancreatic Cancer Day! Today is all about raising awareness and honoring those affected by this challenging disease. Pancreatic cancer may be tough, but together we can make a difference. Join us as we delve into the internet and national history of this important observance.

When is Pancreatic Cancer Day?

It's national pancreatic cancer day on the 13th November.

The Internet History of National Pancreatic Cancer Day

On November 13, 2015, the online world buzzed with support and information surrounding National Pancreatic Cancer Day. With 33 mentions across various platforms, people from all walks of life came together to shed light on the difficulties faced by those battling pancreatic cancer.

This day serves as a reminder to educate ourselves and others about the signs, symptoms, and risks associated with this particular form of cancer. By raising awareness, we strive to promote early detection and improve treatment options.

Throughout the years, countless individuals have taken to social media to share personal stories, express solidarity, and provide resources for coping with pancreatic cancer. The internet has become a powerful tool in connecting and supporting those affected by this disease.

The True National History of Pancreatic Cancer Day

While the internet history of National Pancreatic Cancer Day traces back to 2015, the official national observance dates back even further. This day was established to coincide with Pancreatic Cancer Awareness Month, which takes place every November.

Pancreatic Cancer Awareness Month was first designated in 1999 by the Pancreatic Cancer Action Network (PanCAN) and has since gained significant recognition. During this month, numerous events and initiatives are organized to raise funds and spread awareness about the disease.

By designating a specific day within this month to focus solely on pancreatic cancer, National Pancreatic Cancer Day provides an opportunity to further highlight this illness and its impact on individuals and their loved ones.

History behind the term 'Pancreatic Cancer'

1812

Discovery of the pancreas

In 1812, German anatomist Johann Conrad Brunner discovered the pancreas, a long, flattened gland located in the abdomen. Initially, the pancreas was only recognized for its role in digestion, producing enzymes that break down food. However, its association with cancer was not yet understood.

1932

Identification of pancreatic cancer

In 1932, American surgeon Francis C. Wood identified and named the disease "pancreatic cancer." He observed a distinctive pattern of symptoms and characteristics in patients, including weight loss, pain in the upper abdomen, and jaundice. Wood's classification laid the foundation for further research and understanding of the disease.

1941

First successful surgical treatment

In 1941, Dr. Allen Oldfather Whipple performed the first successful surgical treatment for pancreatic cancer. Known as the Whipple procedure, it involves the removal of the head of the pancreas, part of the small intestine, the gallbladder, and the bile duct. This pioneering surgery offered hope to patients with localized tumors and paved the way for future advancements in pancreatic cancer treatment.

1957

Introduction of chemotherapy

In 1957, the first chemotherapy drug specifically targeting pancreatic cancer, 5-Fluorouracil (5-FU), was introduced. While early chemotherapy treatments had limited success, this marked a significant step forward in the medical management of the disease. Over time, new chemotherapy agents and combination therapies have been developed to improve outcomes for patients.

1991

Identification of tumor markers

In 1991, a tumor marker called CA 19-9 was identified and associated with pancreatic cancer. Tumor markers are substances found in the blood or urine that indicate the presence of a tumor. Although CA 19-9 is not specific to pancreatic cancer and can be elevated in other conditions, it has become a valuable tool for monitoring disease progression and treatment response.

2009

Advancements in targeted therapy

In 2009, a breakthrough in targeted therapy for pancreatic cancer occurred with the approval of the drug Erlotinib. This targeted therapy specifically inhibits a protein called epidermal growth factor receptor (EGFR), which is commonly overexpressed in pancreatic cancer cells. It represented a significant milestone in the quest for more effective treatments tailored to the unique molecular characteristics of pancreatic cancer.

Did you know?

Did you know? Purple is the official color of pancreatic cancer awareness. So, why not wear something purple today to show your support for those affected?